Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Gene–brain–behavior mechanisms underlying autism spectrum disorder: implications for precision psychiatry
    Published on 2023-09-16
    3 years ago
  • Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
    Published on 2023-09-15
    3 years ago
  • Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia
    Published on 2023-09-15
    3 years ago
  • Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
    Published on 2023-09-14
    3 years ago
  • Practical recommendations to improve retention of underrepresented minorities in science and medicine: an early career perspective
    Published on 2023-09-11
    3 years ago
  • Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
    Published on 2023-09-08
    3 years ago
  • Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinking
    Published on 2023-09-08
    3 years ago
« Previous 1 … 118 119 120 121 122 … 143 Next »
Journal of Psychopharmacology
  • Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents
    Published on 2020-07-10
    6 years ago
  • Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP
    Published on 2020-07-10
    6 years ago
  • The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder
    Published on 2020-07-10
    6 years ago
  • Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies
    Published on 2020-07-10
    6 years ago
  • Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
    Published on 2020-07-10
    6 years ago
  • The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies
    Published on 2020-07-10
    6 years ago
  • Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression
    Published on 2020-07-09
    6 years ago
« Previous 1 … 118 119 120 121 122 … 154 Next »
European Neuropsychopharmacology
  • P.226 The impact of early life stress on heterogeneity in future stress response: a longitudinal study in mice
    Published on 2021-02-26
    6 years ago
  • P.223 Time course of antidepressant actions of lurasidone treatment towards the identification of early biomarkers of response
    Published on 2021-02-26
    6 years ago
  • P.225 Differential social fear response in mice is not affected by microbiota depletion
    Published on 2021-02-26
    6 years ago
  • P.332 Large-scale brain networks functional connectivity characteristics of rTMS-therapy in chronic migraine patients
    Published on 2021-02-26
    6 years ago
  • P.323 Association between statins, depressive symptoms and cognition in patients with subjective cognitive decline
    Published on 2021-02-26
    6 years ago
  • P.324 White matter connectivity as a predictor of rTMS effect in obsessive-compulsive disorder: two analytical approaches
    Published on 2021-02-26
    6 years ago
  • P.325 Amygdala-centered morphological correlates of the human startle reflex in a spectral healthy/affective disorders sample
    Published on 2021-02-26
    6 years ago
« Previous 1 … 118 119 120 121 122 … 170 Next »

   Pharma Pub